Orthofix posts investor presentation outlining strategy to drive profitable growth in musculoskeletal care
PUBT·06/01/2026 20:32:35
Listen to the news
- Orthofix outlined a push to “drive profitable growth” across spine, therapeutic solutions, limb reconstruction, biologics, and 7D FLASH navigation.
- 2026 guidance: net sales USD 838 million to USD 848 million; adjusted EBITDA USD 90 million to USD 93 million.
- TTM net sales about USD 819 million; TTM adjusted EBITDA about USD 84 million; TTM adjusted gross margin about 71.7%.
- Focused on expanding 7D FLASH placements, positioning it as a zero-radiation spine navigation system with 97.8% radiation reduction.
- Free cash flow trend cited as improving from USD -108 million in 2023 to near breakeven in 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orthofix Medical Inc. published the original content used to generate this news brief on June 01, 2026, and is solely responsible for the information contained therein.
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.